DexCom, Inc. vs Spotify Technology — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Spotify Technology trades at $500.5 (market cap $103.00B). The key difference: Spotify Technology is far larger — about 3× DexCom, Inc.'s market cap, and DexCom, Inc. is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals.
| DXCM | SPOT | |
|---|---|---|
Market Cap | $33.79B | $103.00B |
Sector | Health | Media |
52-Week High | $89.53 | $738.53 |
52-Week Low | $54.84 | $412.75 |
Enterprise Value | $33.24B | $92.70B |
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →